Literature DB >> 25894593

Analysis of frequency of deep white matter metastasis on cerebral MRI.

C Seidel1, P Hambsch, K Hering, A Bresch, S Rohde, R-D Kortmann, C Gaudino.   

Abstract

Supratentorial white matter is an important part of the brain and a major site of detrimental effects after whole brain radiotherapy (WBRT). It is not known if prevalence of metastases in white matter justifies standard inclusion of white matter in whole brain treatment. In this retrospective analysis we examined the frequency of metastasis in supratentorial deep cerebral white matter with cerebral magnetic resonance imaging (MRI). Deep white matter (DWM) was defined as white matter in corpus callosum with forceps anterior and posterior and centrum semiovale. Lesions extending from grey matter, gyrus or ventricles into white matter were not classified as DWM metastases. Brain MRI of 198 patients from two centres were analyzed. In total 1330 metastases were counted and only 4.6% were located in DWM. Metastases in DWM were small (median diameter 6 mm). Only 1/41 patients (2%) with a singular metastasis had a DWM metastasis, 2/35 patients (6%) with 2 metastases had a DWM metastasis, 14/79 patients (18%) with 3-9 metastases and 12/43 patients (28%) with >9 metastases had a single or more DWM metastases (p = 0.003). There appeared to be tumor related differences with renal cell carcinoma showing significantly more DWM metastasis (6/17, 35%), than NSCLC (11/85, 13%, p = 0.024), breast cancer (1/20, 5%, p = 0.019) or colorectal cancer (0/10, 0%, p = 0.033). Overall, relevant preservation of DWM from metastases, especially in oligometastatic disease, was shown. This implies that DWM in patients with only few brain metastases is unnecessarily damaged by conventional WBRT.

Entities:  

Mesh:

Year:  2015        PMID: 25894593     DOI: 10.1007/s11060-015-1773-6

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  28 in total

1.  Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases.

Authors:  Anna S Berghoff; Aysegül Ilhan-Mutlu; Carina Dinhof; Manuel Magerle; Monika Hackl; Georg Widhalm; Johannes A Hainfellner; Karin Dieckmann; Josef Pichler; Markus Hutterer; Thomas Melchardt; Rupert Bartsch; Christoph C Zielinski; Peter Birner; Matthias Preusser
Journal:  Neuropathol Appl Neurobiol       Date:  2015-02       Impact factor: 8.090

2.  Leukoencephalopathy after whole-brain radiation therapy plus radiosurgery versus radiosurgery alone for metastatic lung cancer.

Authors:  Edward A Monaco; Amir H Faraji; Oren Berkowitz; Phillip V Parry; Uri Hadelsberg; Hideyuki Kano; Ajay Niranjan; Douglas Kondziolka; L Dade Lunsford
Journal:  Cancer       Date:  2012-06-15       Impact factor: 6.860

Review 3.  Management of brain metastases.

Authors:  Riccardo Soffietti; Roberta Rudā; Roberto Mutani
Journal:  J Neurol       Date:  2002-10       Impact factor: 4.849

4.  Evidence for potentials and limitations of brain plasticity using an atlas of functional resectability of WHO grade II gliomas: towards a "minimal common brain".

Authors:  Tamara Ius; Elsa Angelini; Michel Thiebaut de Schotten; Emmanuel Mandonnet; Hugues Duffau
Journal:  Neuroimage       Date:  2011-03-21       Impact factor: 6.556

5.  Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma.

Authors:  Iris Helfrich; Inka Scheffrahn; Sönke Bartling; Joachim Weis; Verena von Felbert; Mark Middleton; Masahi Kato; Süleyman Ergün; Helmut G Augustin; Dirk Schadendorf
Journal:  J Exp Med       Date:  2010-03-01       Impact factor: 14.307

6.  Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases.

Authors:  Dirk Rades; Andre Pluemer; Theo Veninga; Patrick Hanssens; Juergen Dunst; Steven E Schild
Journal:  Cancer       Date:  2007-11-15       Impact factor: 6.860

7.  Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study.

Authors:  Masaaki Yamamoto; Toru Serizawa; Takashi Shuto; Atsuya Akabane; Yoshinori Higuchi; Jun Kawagishi; Kazuhiro Yamanaka; Yasunori Sato; Hidefumi Jokura; Shoji Yomo; Osamu Nagano; Hiroyuki Kenai; Akihito Moriki; Satoshi Suzuki; Yoshihisa Kida; Yoshiyasu Iwai; Motohiro Hayashi; Hiroaki Onishi; Masazumi Gondo; Mitsuya Sato; Tomohide Akimitsu; Kenji Kubo; Yasuhiro Kikuchi; Toru Shibasaki; Tomoaki Goto; Masami Takanashi; Yoshimasa Mori; Kintomo Takakura; Naokatsu Saeki; Etsuo Kunieda; Hidefumi Aoyama; Suketaka Momoshima; Kazuhiro Tsuchiya
Journal:  Lancet Oncol       Date:  2014-03-10       Impact factor: 41.316

8.  Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.

Authors:  Eric L Chang; Jeffrey S Wefel; Kenneth R Hess; Pamela K Allen; Frederick F Lang; David G Kornguth; Rebecca B Arbuckle; J Michael Swint; Almon S Shiu; Moshe H Maor; Christina A Meyers
Journal:  Lancet Oncol       Date:  2009-10-02       Impact factor: 41.316

9.  Distribution of brain metastases.

Authors:  J Y Delattre; G Krol; H T Thaler; J B Posner
Journal:  Arch Neurol       Date:  1988-07

10.  Cognitive functions in survivors of primary central nervous system lymphoma.

Authors:  D D Correa; L M DeAngelis; W Shi; H Thaler; A Glass; L E Abrey
Journal:  Neurology       Date:  2004-02-24       Impact factor: 9.910

View more
  3 in total

1.  A low percentage of metastases in deep brain and temporal lobe structures.

Authors:  Ted K Yanagihara; J Ricardo McFaline-Figueroa; Nicholas J Giacalone; Albert W Lee; Vikram Soni; Mark E Hwang; Kristin T Hsieh; Anurag Saraf; Cheng-Chia Wu; Daniel Yang; Patrick Y Wen; Hani Ashamalla; Ayal A Aizer; Tony J C Wang; Raymond Y Huang
Journal:  Neuro Oncol       Date:  2019-05-06       Impact factor: 12.300

2.  White matter lesions reduce number of brain metastases in different cancers: a high-resolution MRI study.

Authors:  Benjamin-Andreas Berk; Sandra Nagel; K Hering; S Paschke; Karl-Titus Hoffmann; Rolf-Dieter Kortmann; Chiara Gaudino; Clemens Seidel
Journal:  J Neurooncol       Date:  2016-08-17       Impact factor: 4.130

Review 3.  Anatomical and topographical variations in the distribution of brain metastases based on primary cancer origin and molecular subtypes: a systematic review.

Authors:  Tyler Cardinal; Dhiraj Pangal; Ben A Strickland; Paul Newton; Saeedeh Mahmoodifar; Jeremy Mason; David Craig; Thomas Simon; Ben Yi Tew; Min Yu; Wensha Yang; Eric Chang; Ryan P Cabeen; Jacob Ruzevick; Arthur W Toga; Josh Neman; Bodour Salhia; Gabriel Zada
Journal:  Neurooncol Adv       Date:  2021-11-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.